Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-053236

EVP, Research & CSO sold 13,750 shares at $50.00 ($687,500)

  • EVP, Research & CSO acquired 13,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Virgin Herbert EVP, Research & CSO 2021-08-23 Option exercise +13,750 $1.53 $21,038 113,450 D
Virgin Herbert EVP, Research & CSO 2021-08-23 Sale −13,750 $50.00 $687,500 99,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2021-08-23 Option exercise · Stock Option (Right to Buy) −13,750 271,505 D
Open-market sales · 13,750 sh · avg $50.00 · $687,500
Loading xslF345X03/doc4.xml…